← All stocks

TENAX THERAPEUTICS, INC.

TENX Net buying
CIK 0000034956 #4570 in the set updated 17 Sep 2026
Bought (12 mo)
$5.02M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$5.02M
+$5.02M against sales at will

By person

6 insiders · 25 transactions
0.0×

Christopher T. Giordano holds only 0.0 times base salary in stock. $40.40K of shares against $563.73K in salary for 2025.

Salary from the company's own proxy. The shares are what Christopher T. Giordano last reported holding, valued at $1.82, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ADAR1 Capital Management, LLC entity
10% owner
$4.80M (7)
+$4.80M
11,377,969
$20.73M
+31.1%
Rich Stuart
Chief Medical Officer
$96.41K (5)
+$96.41K
10,266
$18.71K
+3,759%
MCGAULEY THOMAS
Interim CFO
$58.16K (3)
+$58.16K
7,000
$12.75K
Giordano Christopher Thomas
CEO
$40.09K (5)
+$40.09K
22,174
$40.40K
Almenoff June Sherie
Director
$14.94K (2)
+$14.94K
1,993
$3.63K
STAAB THOMAS R II
Chief Financial Officer
$10.98K (1)
+$10.98K
15,675
$28.56K

No percentages here. This company's share count has moved by a factor of 11.0 over the window, from 3,408,906 to 37,423,917 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Giordano Christopher Thomas
13 Jul 2026
CEO
Exercised, kept
8,500
$5.94
$50.49K
Giordano Christopher Thomas
13 Jul 2026
CEO
Exercised, kept
219
$3.55
$777.23

What was left out

Form 4 filings counted 20
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 18,719
History held since 20 Oct 2016